Literature DB >> 15612831

Validation of the work and health interview.

Walter F Stewart1, Judith A Ricci, Carol Leotta, Elsbeth Chee.   

Abstract

BACKGROUND: Instruments that measure the impact of illness on work do not usually provide a measure that can be directly translated into lost hours or costs. We describe the validation of the Work and Health Interview (WHI), a questionnaire that provides a measure of lost productive time (LPT) from work absence and reduced performance at work.
METHOD: A sample (n = 67) of inbound phone call agents was recruited for the study. Validity of the WHI was assessed over a 2-week period in reference to workplace data (i.e. absence time, time away from call station and electronic continuous performance) and repeated electronic diary data (n = 48) obtained approximately eight times a day to estimate time not working (i.e. a component of reduced performance).
RESULTS: The mean (median) missed work time estimate for any reason was 11 (8.0) and 12.9 (8.0) hours in a 2-week period from the WHI and workplace data, respectively, with a Pearson's (Spearman's) correlation of 0.84 (0.76). The diary-based mean (median) estimate of time not working while at work was 3.9 (2.8) hours compared with the WHI estimate of 5.7 (3.2) hours with a Pearson's (Spearman's) correlation of 0.19 (0.33). The 2-week estimate of total productive time from the diary was 67.2 hours compared with 67.8 hours from the WHI, with a Pearson's (Spearman's) correlation of 0.50 (0.46).
CONCLUSION: At a population level, the WHI provides an accurate estimate of missed time from work and total productive time when compared with workplace and diary estimates. At an individual level, the WHI measure of total missed time, but not reduced performance time, is moderately accurate.

Mesh:

Year:  2004        PMID: 15612831     DOI: 10.2165/00019053-200422170-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  48 in total

1.  Health, safety, and productivity in a manufacturing environment.

Authors:  W B Bunn; D B Pikelny; T J Slavin; S Paralkar
Journal:  J Occup Environ Med       Date:  2001-01       Impact factor: 2.162

2.  Health, productivity, and occupational medicine.

Authors:  P Brandt-Rauf; W N Burton; R J McCunney
Journal:  J Occup Environ Med       Date:  2001-01       Impact factor: 2.162

3.  Health and productivity management: emerging opportunities for health promotion professionals for the 21st century.

Authors:  R Z Goetzel; R J Ozminkowski
Journal:  Am J Health Promot       Date:  2000 Mar-Apr

4.  The cost of productivity losses associated with allergic rhinitis.

Authors:  J Crystal-Peters; W H Crown; R Z Goetzel; D C Schutt
Journal:  Am J Manag Care       Date:  2000-03       Impact factor: 2.229

5.  The work impact of asthma and rhinitis: findings from a population-based survey.

Authors:  P D Blanc; L Trupin; M Eisner; G Earnest; P P Katz; L Israel; E H Yelin
Journal:  J Clin Epidemiol       Date:  2001-06       Impact factor: 6.437

6.  Validation of a migraine work and productivity loss questionnaire for use in migraine studies.

Authors:  G M Davies; N Santanello; W Gerth; D Lerner; G A Block
Journal:  Cephalalgia       Date:  1999-06       Impact factor: 6.292

7.  Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life.

Authors:  P Wahlqvist
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

8.  Recovery from depression, work productivity, and health care costs among primary care patients.

Authors:  G E Simon; D Revicki; J Heiligenstein; L Grothaus; M VonKorff; W J Katon; T R Hylan
Journal:  Gen Hosp Psychiatry       Date:  2000 May-Jun       Impact factor: 3.238

9.  Measuring productivity loss days in asthma patients. The Pharmacy Medication Monitoring Program and Advisory Board.

Authors:  W J Ungar; P C Coyte
Journal:  Health Econ       Date:  2000-01       Impact factor: 3.046

10.  The multinational impact of migraine symptoms on healthcare utilisation and work loss.

Authors:  W C Gerth; G W Carides; E J Dasbach; W H Visser; N C Santanello
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

View more
  11 in total

Review 1.  Employee health and presenteeism: a systematic review.

Authors:  Alyssa B Schultz; Dee W Edington
Journal:  J Occup Rehabil       Date:  2007-07-25

Review 2.  The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research.

Authors:  Wayne N Burton; Stephen H Landy; Kristen E Downs; M Chris Runken
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

Review 3.  The cost and impact of health conditions on presenteeism to employers: a review of the literature.

Authors:  Alyssa B Schultz; Chin-Yu Chen; Dee W Edington
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 4.  Estimating productivity costs in health economic evaluations: a review of instruments and psychometric evidence.

Authors:  Kenneth Tang
Journal:  Pharmacoeconomics       Date:  2015-01       Impact factor: 4.981

Review 5.  Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life.

Authors:  Dawn C Buse; Marcia F T Rupnow; Richard B Lipton
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

6.  Estimating the Impact of Diabetes Mellitus on Worker Productivity Using Self-Report, Electronic Health Record and Human Resource Data.

Authors:  David C Tabano; Melissa L Anderson; Debra P Ritzwoller; Arne Beck; Nikki Carroll; Paul A Fishman; David C Grossman
Journal:  J Occup Environ Med       Date:  2018-11       Impact factor: 2.162

7.  Association of Controlled and Uncontrolled Hypertension With Workplace Productivity.

Authors:  Victoria Unmuessig; Paul A Fishman; Hubertus J M Vrijhoef; Arianne M J Elissen; David C Grossman
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-17       Impact factor: 3.738

Review 8.  Economic Theory and Self-Reported Measures of Presenteeism in Musculoskeletal Disease.

Authors:  Cheryl Jones; Katherine Payne; Brenda Gannon; Suzanne Verstappen
Journal:  Curr Rheumatol Rep       Date:  2016-08       Impact factor: 4.592

Review 9.  Quality appraisal of generic self-reported instruments measuring health-related productivity changes: a systematic review.

Authors:  Cindy Y G Noben; Silvia M A A Evers; Frans J Nijhuis; Angelique E de Rijk
Journal:  BMC Public Health       Date:  2014-02-04       Impact factor: 3.295

Review 10.  Challenges in measuring and valuing productivity costs, and their relevance in mood disorders.

Authors:  Benedikte R Lensberg; Michael F Drummond; Natalya Danchenko; Nicolas Despiégel; Clément François
Journal:  Clinicoecon Outcomes Res       Date:  2013-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.